Blood Preparations Market to Reach US$80.2 Billion by 2032, Supported by Rising Demand for Plasma-Derived Therapies and Transfusion Products
Industry Experts, Inc. has unveiled its latest market research publication, "Blood Preparations - A Global Market Overview," estimating that global revenues will rise from US$54 billion in 2025 to US$80.2 billion by 2032, registering a CAGR of 5.8% during 2025-2032. Growth is supported by rising incidences of chronic and hematologic diseases, an aging global population, and expanding demand for transfusions, plasma-derived therapies, and antithrombotic medications used across cardiovascular, surgical, and trauma care. Growing utilization of immunoglobulins, albumin, and coagulation factors, along with increasing use of anticoagulants and platelet aggregation inhibitors, is driving sustained clinical demand. Advancements in plasma fractionation, pathogen reduction, automated blood processing, and biologics manufacturing continue to improve product safety, efficacy, and traceability. Government-led blood donation initiatives, expanding transfusion infrastructure, improvements in screening technologies, and heightened awareness of blood-related disorders further contribute to market growth. However, donor shortages, transfusion-transmitted infection concerns, and rising costs of plasma-derived therapies pose notable challenges. North America leads the global market with a 40% share in 2025, supported by strong demand for plasma-derived therapies, a well-established blood banking network, advanced healthcare infrastructure, and stringent FDA-regulated safety standards. In contrast, Asia-Pacific is projected to grow the fastest at a 7.5% CAGR, driven by expanding healthcare capacity, government investment in plasma self-sufficiency, growing awareness of voluntary blood donation, and rising incidence of chronic diseases and surgical procedures. China, India, and Japan represent key growth hubs due to national blood programs and rapid adoption of modern transfusion technologies.
Industry Experts, Inc. has unveiled its latest market research publication, "Blood Preparations - A Global Market Overview," estimating that global revenues will rise from US$54 billion in 2025 to US$80.2 billion by 2032, registering a CAGR of 5.8% during 2025-2032. Growth is supported by rising incidences of chronic and hematologic diseases, an aging global population, and expanding demand for transfusions, plasma-derived therapies, and antithrombotic medications used across cardiovascular, surgical, and trauma care.
Growing utilization of immunoglobulins, albumin, and coagulation factors, along with increasing use of anticoagulants and platelet aggregation inhibitors, is driving sustained clinical demand. Advancements in plasma fractionation, pathogen reduction, automated blood processing, and biologics manufacturing continue to improve product safety, efficacy, and traceability. Government-led blood donation initiatives, expanding transfusion infrastructure, improvements in screening technologies, and heightened awareness of blood-related disorders further contribute to market growth. However, donor shortages, transfusion-transmitted infection concerns, and rising costs of plasma-derived therapies pose notable challenges.
North America leads the global market with a 40% share in 2025, supported by strong demand for plasma-derived therapies, a well-established blood banking network, advanced healthcare infrastructure, and stringent FDA-regulated safety standards. In contrast, Asia-Pacific is projected to grow the fastest at a 7.5% CAGR, driven by expanding healthcare capacity, government investment in plasma self-sufficiency, growing awareness of voluntary blood donation, and rising incidence of chronic diseases and surgical procedures. China, India, and Japan represent key growth hubs due to national blood programs and rapid adoption of modern transfusion technologies.
Transform your PDFs into Flipbooks and boost your revenue!
Leverage SEO-optimized Flipbooks, powerful backlinks, and multimedia content to professionally showcase your products and significantly increase your reach.
Blood Preparations Market to Reach US$80.2 Billion by
2032, Supported by Rising Demand for Plasma-Derived
Therapies and Transfusion Products
Thursday Nov 27, 2025
Industry Experts, Inc. has unveiled its latest market research publication, "Blood Preparations
- A Global Market Overview," estimating that global revenues will rise from US$54 billion in
2025 to US$80.2 billion by 2032, registering a CAGR of 5.8% during 2025-2032. Growth is
supported by rising incidences of chronic and hematologic diseases, an aging global
population, and expanding demand for transfusions, plasma-derived therapies, and
antithrombotic medications used across cardiovascular, surgical, and trauma care.
Growing utilization of immunoglobulins, albumin, and coagulation factors, along with
increasing use of anticoagulants and platelet aggregation inhibitors, is driving sustained
clinical demand. Advancements in plasma fractionation, pathogen reduction, automated blood
processing, and biologics manufacturing continue to improve product safety, efficacy, and
traceability. Government-led blood donation initiatives, expanding transfusion infrastructure,
improvements in screening technologies, and heightened awareness of blood-related
disorders further contribute to market growth. However, donor shortages, transfusiontransmitted
infection concerns, and rising costs of plasma-derived therapies pose notable
challenges.
© Industry Experts, Inc. All Rights Reserved
North America leads the global market with a 40% share in 2025, supported by strong
demand for plasma-derived therapies, a well-established blood banking network, advanced
healthcare infrastructure, and stringent FDA-regulated safety standards. In contrast, Asia-
Pacific is projected to grow the fastest at a 7.5% CAGR, driven by expanding healthcare
capacity, government investment in plasma self-sufficiency, growing awareness of voluntary
blood donation, and rising incidence of chronic diseases and surgical procedures. China,
India, and Japan represent key growth hubs due to national blood programs and rapid
adoption of modern transfusion technologies.
By product type, Whole Blood accounts for the largest share at 42.5% in 2025, reflecting its
critical role in emergency transfusions, surgeries, trauma management, and widespread
availability in developing regions. Conversely, Blood Derivatives are projected to grow the
fastest at a 6.3% CAGR, supported by rising use of immunoglobulins, albumin, and
coagulation factors for immune, hepatic, and bleeding disorders. By antithrombotic and
anticoagulant type, Anticoagulants dominate with a 62% share in 2025, fueled by high
prevalence of thromboembolic diseases and strong adoption of LMWHs and DOACs. Platelet
Aggregation Inhibitors are expected to expand the fastest at 6.2% CAGR, supported by rising
interventional cardiology procedures.
By application, Thrombocytosis leads with 37% share in 2025, driven by high demand for
platelet-related diagnostics and treatments across hematology and oncology. Meanwhile,
Angina and Blood Vessel Complications is the fastest-growing application segment at 6.6%
CAGR, driven by global cardiovascular disease prevalence, adoption of long-term antiplatelet
therapies, and expanding R&D pipelines. By end user, Hospitals dominate with 53% share,
reflecting high surgical volumes, trauma care demand, and integrated transfusion services.
Blood Banks are the fastest-growing end user at 6.5% CAGR, supported by expanding
plasma collection capacity, improved storage technologies, and increased donor mobilization
efforts.
The report segments the global Blood Preparations market by Product Type (Whole Blood,
Blood Components, Blood Derivatives), Antithrombotic & Anticoagulants Type
(Anticoagulants, Platelet Aggregation Inhibitors, Fibrinolytics), Application (Thrombocytosis,
Pulmonary Embolism, Renal Impairment, Angina & Blood Vessel Complications, Other
Applications), and End User (Hospitals, Blood Banks, Diagnostic Laboratories, Academic and
Research Institutions). Geographic coverage spans North America, Europe, Asia-Pacific,
South America, and Rest of World, and the study includes profiles of 11+ companies such as
CSL Behring, Grifols, Baxter, Octapharma, Pfizer, Sanofi, AstraZeneca, and Boehringer
Ingelheim.
For sample pages or purchase options, call +1-320-497-3787 or visit Blood Preparations
Market Report.
© Industry Experts, Inc. All Rights Reserved
About Industry Experts, Inc.
Industry Experts, Inc. ranks among the leading global market research providers. The
company's off-the-shelf and customized intelligence reports offer strategic insights and
valuable guidance to corporate strategists, analysts, researchers, and startups seeking
reliable current and future market data. For more information, contact +1-320-497-3787 or
visit https://industry-experts.com.
© Industry Experts, Inc. All Rights Reserved
Change language